The chemical substance known as "2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside - L-threo-hex-1-enofuranos-3-ulose" with CAS number 8067-12-7 is a complex glycoside that features a chromone backbone, which is characterized by a fused benzopyran structure. This compound contains multiple hydroxyl groups, contributing to its potential antioxidant properties. The presence of sugar moieties, specifically a glucopyranoside and a deoxy-mannopyranosyl unit, suggests that it may exhibit biological activity, possibly influencing its solubility and interaction with biological systems. The specific stereochemistry indicated by the "L-threo" designation implies a particular spatial arrangement of atoms, which can affect the compound's reactivity and biological function. Overall, this substance may be of interest in pharmacological research due to its structural complexity and potential health benefits, although further studies would be necessary to elucidate its specific properties and applications.

Ascorbic acid, rutoside drug combination is used in treatment of diabetic retinopathy.

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside - L-threo-hex-1-enofuranos-3-ulose (1:1)

8067-12-7: The chemical substance known as "2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside - L-threo-hex-1-enofuranos-3-ulose" with CAS number 8067-12-7 is a complex glycoside that features a chromone backbone, which is characterized by a fused benzopyran structure. This compound contains multiple hydroxyl groups, contributing to its potential antioxidant properties. The presence of sugar moieties, specifically a glucopyranoside and a deoxy-mannopyranosyl unit, suggests that it may exhibit biological activity, possibly influencing its solubility and interaction with biological systems. The specific stereochemistry indicated by the "L-threo" designation implies a particular spatial arrangement of atoms, which can affect the compound's reactivity and biological function. Overall, this substance may be of interest in pharmacological research due to its structural complexity and potential health benefits, although further studies would be necessary to elucidate its specific properties and applications.

<p>Ascorbic acid, rutoside drug combination is used for treating diabetic retinopathy.</p>

CAS 8067-12-7

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside - L-threo-hex-1-enofuranos-3-ulose (1:1)

Ascorbic acid, rutoside drug combination

Ref: TM-T23757